NSEAcquisition13 Jul 2026 · 13 Jul 2026, 05:06 pm
Acquisition
Indo-National Limited · NIPPOBATRY
✦ AI Summaryacquisition
Indo-National Limited has informed the Exchange about Acquisition of an additional 1.18% equity stake in Medcuore Medical Solutions Private Ltd for Rs. 74,90,808.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indo-National Limited has informed the Exchange about Acquisition
Attachments (1)
📄pdf
Download →
NIPPOBATRY_13072026170552_INL_Stock_Exchange_Disclosuresd.pdf
View document text
13th July 2026
BSE Limited
National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers,
"Exchange Plaza", 5th Floor,
Dalal Street, Fort,
Plot No. C/1, G Block Bandra-Kurla Complex
Mumbai 400 001
Bandra (East), Mumbai 400 051
Scrip code: 504058
NSE SYMBOL: NIPPOBATRY
Dear Sir/Madam,
Sub: Intimation under Regulation 30 read with Schedule III of Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“SEBI LODR”), as amended read with the Securities and Exchange Board of India
(“SEBI”) master circular dated November 11, 2024, bearing reference no.
SEBI/HO/CFD/PoD2/CIR/P/0155 (“SEBI Circular”)
Pursuant to the provisions of Regulation 30 of the SEBI LODR, and with reference to the earlier
intimation dated May 30, 2026, we would like to inform that the Company has invested an
aggregate amount of Rs. 74,90,808 (Rupees Seventy-four lakh ninety thousand eight hundred
and eight only), by way of subscription to Equity Shares of Medcuore Medical Solutions
Private Ltd (“MMSPL”).
The said investment represents an additional 1.18% of the paid-up share capital in MMSPL on
a fully diluted basis.
The disclosure required under Schedule III of the SEBI LODR read with the SEBI Circular, is
enclosed herewith as Annexure-A.
Kindly take the above on your record.
For Indo National Limited
J. Srinivasan
Company Secretary
lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034.
Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006.
CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in
ANNEXURE – A
Disclosure of information as required under SEBI circular are as follows:-
Particulars Details
1. name of the target entity, details Name: Medcuore Medical Solutions Private Ltd
in brief such as size, turnover
etc.; Turnover (FY 25-26): Rs. 1,45,60,000
2. whether the acquisition would Pursuant to an additional primary investment of
fall within related party Rs. 74,90,808, the Company has acquired a
transaction(s) and whether the further 1.18% equity stake in MMSPL. Following
promoter/ promoter group/ this acquisition, the Company’s aggregate
group companies have any shareholding in MMSPL now stands at 60.34%.
interest in the entity being The acquisition would not fall under related
acquired? If yes, nature of party transaction. None of the promoter/
interest and details thereof and promoter group/ group companies have any
whether the same is done at interest in the entity being acquired.
“arm’s length”
3. Industry to which the entity MMSPL is engaged in the business of
being acquired belongs manufacturing, distribution and providing
services in relation to Air Monitoring System and
Air Purifiers.
4. objects and impact of acquisition Object and impact: To facilitate business growth
(including but not limited to, and to generate revenue and to earn profit due
disclosure of reasons for to expansion of business
acquisition of target entity, if its
business is outside the main line
of business of the listed entity);
5. brief details of any governmental Nil
or regulatory approvals required
for the acquisition;
6. Indicative time period for Upto FY 2027-28
completion of the acquisition
lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034.
Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006.
CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in
Particulars Details
7. Consideration- whether cash Cash consideration
consideration or share swap or
any other form and details of the
same.
8. Cost of acquisition and/or the The shares were acquired based on valuation
price at which the shares are report issued by registered valuer. The price per
acquired; share is Rs. 16,536/- (Rupees Sixteen thousand
five hundred and thirty six).
9. Percentage of shareholding / An additional 1.18% of the paid-up share capital
control acquired and / or number in MMSPL has been acquired, taking the
of shares acquired Company’s total shareholding to 60.34%.
Number of shares acquired: 453 shares
10. Brief background about the a. Name: Medcuore Medical Solutions Private
entity acquired in terms of Ltd
products/line of business
acquired, date of incorporation, b. Product and Line of Business: business of
history of last 3 years turnover, manufacturing, distribution and providing
country in which the acquired services in relation to Air Monitoring System and
entity has presence and any Air Purifiers.
other significant information (in
c. Date of Incorporation: 07/06/2020
brief)
d. Last 3 years turnover:
FY 26 Rs. 1,45,60,000
FY 25 Rs. 35,41,484
FY24 Rs. 47,68,000
e. country in which the acquired entity has
presence: India
lndo National Limited I Corporate office address: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034.
Registered office address: No. 609, Mount Road, Lakshmi Bhawan IVth FLOOR, Chennai- 600006.
CIN No: L31909TN1972PLC006196 I feedback@nippo.in I 044-2827 2711, 044-2824 2700 I www.nippo.in